TenderlineUK
Procurement Intelligence
Official OCDSSearch
Find a TenderAwarded without competitionContract termination notice
Published 20 Apr 2026, 14:35 BST

Official UK procurement notice

RISANKIZUMAB 360MG SOLUTION FOR INJECTION HOMECARE

Authority: Belfast Health & Social Care Trust (Central government)

Direct award
Sectors: Medical Devices & Pharma (33) Delivery: Northern Ireland (UKN)
Awarded value£640,000published award · exc. VAT
Awarded 21 May 2025no call for competition
Awarded to Sciensus Pharma Services Ltd

What is being bought

Published requirement description

Procurement of RISANKIZUMAB 360MG SOLUTION FOR INJECTION HOMECARE

The lotProcurement structure

single lot · no lot value published
Lot #1Lot 1Awarded
Delivery: Northern Ireland
33600000 Pharmaceutical products

Procedure terms & legal framework

From the official record
Procedure method
Direct award
Legal basis
UKPGA · 2023/54 Procurement Act 2023
Notice status
Awarded without competition
Procurement threshold
Unspecified in notice
Regulatory regime
Standard
Commercial structure
Stand-alone contract (no framework)
Competition type
Direct award — no call for competition
GPA / WTO covered
Yes (GPA)
Recurring procurement
No (one-off requirement)
First published
20 Apr 2026, 14:35 BST
Last source update
20 Apr 2026, 14:35 BST
Authority reference
DACPM2025-23
Latest notice
Contract termination notice (UK11)
Delivery area
Northern Ireland (UKN)
Official registry OCID
ocds-h6vhtk-0519f1
Why no open competition
Additional Repeat Extension Partial Replacement
Published justification
These essential medicines are required from this supplier to ensure continuity of patient care, specifically for homecare support. The absence of competition is not the artificial narrowing of the parameters of the procurement

How it was run

Submission deadline
—

Timeline

2 published dates · Europe/London
  1. Standstill ends
    2 Jun 2025, 23:59 BST
  2. Notice published158 days ago
    20 Apr 2026, 14:35 BST

Commercial outcome & contract awards

Published awards, contracts and bid statistics — not a forecast
Awards 1
Awarded value £640,0001 award exc. VAT
Contracts signed 1latest 3 Jun 2025
Awarded toValueDateStatus
Sciensus Pharma Services Ltd17 Jun 2025 — 30 Jun 2027£640,00021 May 2025Awarded

Contracts

  • RISANKIZUMAB 360MG SOLUTION FOR INJECTION HOMECARE · Sciensus Pharma Services Ltd

    Signed
    3 Jun 2025
    Value
    £640,000
    Period
    3 Jun 2025 — 30 Jun 2027
    Status
    terminated
    Final value
    £640,000
    Termination
    other

    No agreed KPIs: Contract value is below the relevant threshold for Key performance indicators

Notice history

8 events · 4 releases on Find a Tender · since 21 May 2025
  1. Contract termination notice published
    20 Apr 2026, 14:35 BSTUK11
  2. Status changed
    20 Apr 2026, 14:35 BST
  3. Procurement method changed
    20 Apr 2026, 14:35 BST
  4. Buyer details updated
    20 Apr 2026, 14:35 BST
  5. Contract signature expected
    16 Jun 2025, 23:59 BSTscheduled
  6. Contract details notice published
    6 Jun 2025, 13:59 BSTUK7
  7. Contract award notice published
    21 May 2025, 10:33 BSTUK6
  8. Transparency notice published
    21 May 2025, 10:24 BSTUK5
Routine re-releases (4)
  • 2025-05: 1 release · 21 May 2025

Contracting authority & participating public bodies

Belfast Health & Social Care Trust

Contracting authorityPublic authority - central governmentNorthern Irish devolved regulations apply GB-PPON: PLQJ-5727-JCLR Trust Headquarters, 2nd Floor, Non Clinical Support Building, Royal Victoria Hospital, Belfast, Northern Ireland, BT12 6BA [email protected]

Bidders & participating suppliers

1 commercial party on the notice

Official documents & specifications (5)

Official links; attachments are not copied

Tender pack and attachments

  • Conflict of interest declarationtenderConflict of interest declarationNot published

Notices published for this procedure